大成生化(00809.HK)大成糖業(03889.HK)附屬共8,000萬人幣貸款違約未能償還
大成生化(00809.HK)及大成糖業(03889.HK)聯合公布,由於違反貸款協議,成員公司所欠貸款已即時到期,共涉及8,000萬元人民幣(下同)。
其中,大成生化附屬哈爾濱大成與大興安嶺銀行所訂立的貸款協議,涉及未償還本金5,000萬元及未償還利息,哈爾濱大成已就該貸款提供抵押品。
大成糖業附屬錦州元成與中國銀行訂立的定期貸款,涉及未償還本金3,000萬元及未償還利息。
大成生化及大成糖業表示,截至目前,哈爾濱大成及錦州元成未有獲得大興安嶺銀行及中國銀行錦州支行授出任何豁免,未能償還中國銀行錦州支行貸款亦可能觸發由大成糖業集團訂立的其他貸款協議的交叉違約,就債務重組下一步進展或詳情將適時作出進一步公告。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.